Table 3.
Meta-Analysis for Likelihood Ratio Tests for Improved Prognostic Value: Meta-Analysis of Evaluable Patients (n = 1,735)
| Comparison | Likelihood Ratio | df | P |
|---|---|---|---|
| RSPC v RS alone | 76.9 | 8 | < .001 |
| RSPC v tumor grade, tumor size, and age | 45.4 | 4 | < .001 |
Abbreviations: RS, recurrence score; RSPC, recurrence score– pathology–clinical.